Wednesday, August 9 | 11 a.m.–noon CT An educational overview of the large category of peripheral neuropathies, discussing various testing platforms strengths and weaknesses, with a focus on identifying hereditary neuropathies.
By MML Education • July 12, 2017
Wednesday, August 30 | Noon–1 p.m. CT This presentation offers an educational overview of next-generation sequencing (NGS) testing for hematologic malignancies, specifically myeloid disorders and multiple myeloma.
By MML Education • July 6, 2017


Originally Presented June 12, 2017 This presentation offers an educational overview of autoimmune central nervous system disorders, evaluations (including antibody testing), and treatments.
By Mayo Medical Laboratories • June 22, 2017
Originally Presented February 24, 2017 Chromosome analysis, which was once the preferred genetic test for a wide variety of congenital abnormalities, is now one of the most frequently misordered cytogenetic tests at MML. This webinar will outline the differences in technologies and the appropriate use of each test.
By Mayo Medical Laboratories • March 1, 2017
ST2 is a biomarker of fibrosis and cardiac remodeling and provides clinicians with significant prognostic guidance without being adversely influenced by typical confounders such as age, obesity, and renal impairment.
By Alyssa Frank • October 26, 2016
This one-hour webinar will examine Lp-PLA2 and the benefits of ordering the Lipoprotein-Associated Phospholipase A2 Activity Test (Mayo ID: PLACA) offered by Mayo Medical Laboratories.Tuesday, November 24, 2015 | 2:00 p.m. – 3:00 p.m. CST
By Brent Westra • November 17, 2015